MedTrace Logo

Sentinel Low Risk Registry

NCT04131127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-10-19

No results posted yet for this study

Summary

This registry is designed to quantify embolic debris capture rate in patients at low surgical risk treated with the Sentinel System during TAVI.

Conditions

  • Aortic Valve Stenosis

Interventions

DEVICE

Sentinel Device

Sentinel Device used during TAVI in a Low Risk Patient

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • CVPath Institute Inc.

    lead OTHER

Principal Investigators

  • Aloke V Finn, MD · CVPath Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-07
Primary Completion
2020-08-19
Completion
2020-08-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04131127 on ClinicalTrials.gov